TA, W., JS, T., D, S., MT, L., P, A., C, J., & D, R. (2020). Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial. Obesity (Silver Spring, Md.), 28(3), 529. https://doi.org/10.1002/oby.22726
Chicago Style (17th ed.) CitationTA, Wadden, Tronieri JS, Sugimoto D, Lund MT, Auerbach P, Jensen C, and Rubino D. "Liraglutide 3.0 Mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial." Obesity (Silver Spring, Md.) 28, no. 3 (2020): 529. https://doi.org/10.1002/oby.22726.
MLA (9th ed.) CitationTA, Wadden, et al. "Liraglutide 3.0 Mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial." Obesity (Silver Spring, Md.), vol. 28, no. 3, 2020, p. 529, https://doi.org/10.1002/oby.22726.